Menu
GWAS Study

GWAS for executive function and processing speed suggests involvement of the CADM2 gene.

Ibrahim-Verbaas CA, Bressler J, Debette S et al.

25869804 PubMed ID
GWAS Study Type
43217 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IC
Ibrahim-Verbaas CA
BJ
Bressler J
DS
Debette S
SM
Schuur M
SA
Smith AV
BJ
Bis JC
DG
Davies G
TS
Trompet S
SJ
Smith JA
WC
Wolf C
CL
Chibnik LB
LY
Liu Y
VV
Vitart V
KM
Kirin M
PK
Petrovic K
PO
Polasek O
ZL
Zgaga L
FC
Fawns-Ritchie C
HP
Hoffmann P
KJ
Karjalainen J
LJ
Lahti J
LD
Llewellyn DJ
SC
Schmidt CO
MK
Mather KA
CV
Chouraki V
SQ
Sun Q
RS
Resnick SM
RL
Rose LM
OC
Oldmeadow C
SM
Stewart M
SB
Smith BH
GV
Gudnason V
YQ
Yang Q
MS
Mirza SS
JJ
Jukema JW
DP
deJager PL
HT
Harris TB
LD
Liewald DC
AN
Amin N
CL
Coker LH
SO
Stegle O
LO
Lopez OL
SR
Schmidt R
TA
Teumer A
FI
Ford I
KN
Karbalai N
BJ
Becker JT
JM
Jonsdottir MK
AR
Au R
FR
Fehrmann R
HS
Herms S
NM
Nalls M
ZW
Zhao W
TS
Turner ST
YK
Yaffe K
LK
Lohman K
VS
van Swieten JC
KS
Kardia S
KD
Knopman DS
MW
Meeks WM
HG
Heiss G
HE
Holliday EG
SP
Schofield PW
TT
Tanaka T
SD
Stott DJ
WJ
Wang J
RP
Ridker P
GA
Gow AJ
PA
Pattie A
SJ
Starr JM
HL
Hocking LJ
AN
Armstrong NJ
MS
McLachlan S
SJ
Shulman JM
PL
Pilling LC
EG
Eiriksdottir G
SR
Scott RJ
KN
Kochan NA
PA
Palotie A
HY
Hsieh YC
EJ
Eriksson JG
PA
Penman A
GR
Gottesman RF
OB
Oostra BA
YL
Yu L
DA
DeStefano AL
BA
Beiser A
GM
Garcia M
RJ
Rotter JI
NM
Nöthen MM
HA
Hofman A
SP
Slagboom PE
WR
Westendorp R
BB
Buckley BM
WP
Wolf PA
UA
Uitterlinden AG
PB
Psaty BM
GH
Grabe HJ
BS
Bandinelli S
CD
Chasman DI
GF
Grodstein F
RK
Räikkönen K
LJ
Lambert JC
PD
Porteous DJ
PJ
Price JF
SP
Sachdev PS
FL
Ferrucci L
AJ
Attia JR
RI
Rudan I
HC
Hayward C
WA
Wright AF
WJ
Wilson JF
CS
Cichon S
FL
Franke L
SH
Schmidt H
DJ
Ding J
DC
de Craen A
FM
Fornage M
BD
Bennett DA
DI
Deary IJ
IM
Ikram MA
LL
Launer LJ
FA
Fitzpatrick AL
SS
Seshadri S
VD
van Duijn CM
MT
Mosley TH
Chapter II

Abstract

Summary of the research findings

To identify common variants contributing to normal variation in two specific domains of cognitive functioning, we conducted a genome-wide association study (GWAS) of executive functioning and information processing speed in non-demented older adults from the CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) consortium. Neuropsychological testing was available for 5429-32,070 subjects of European ancestry aged 45 years or older, free of dementia and clinical stroke at the time of cognitive testing from 20 cohorts in the discovery phase. We analyzed performance on the Trail Making Test parts A and B, the Letter Digit Substitution Test (LDST), the Digit Symbol Substitution Task (DSST), semantic and phonemic fluency tests, and the Stroop Color and Word Test. Replication was sought in 1311-21860 subjects from 20 independent cohorts. A significant association was observed in the discovery cohorts for the single-nucleotide polymorphism (SNP) rs17518584 (discovery P-value=3.12 × 10(-8)) and in the joint discovery and replication meta-analysis (P-value=3.28 × 10(-9) after adjustment for age, gender and education) in an intron of the gene cell adhesion molecule 2 (CADM2) for performance on the LDST/DSST. Rs17518584 is located about 170 kb upstream of the transcription start site of the major transcript for the CADM2 gene, but is within an intron of a variant transcript that includes an alternative first exon. The variant is associated with expression of CADM2 in the cingulate cortex (P-value=4 × 10(-4)). The protein encoded by CADM2 is involved in glutamate signaling (P-value=7.22 × 10(-15)), gamma-aminobutyric acid (GABA) transport (P-value=1.36 × 10(-11)) and neuron cell-cell adhesion (P-value=1.48 × 10(-13)). Our findings suggest that genetic variation in the CADM2 gene is associated with individual differences in information processing speed.

Up to 30,807 European ancestry individuals, up to 1,267 Erasmus Rucphen (founder/genetic isolated) individuals, up to 535 Korculan (founder/genetic isolated) individuals, up to 417 Orcadian (founder/genetic isolated) individuals, up to 311 Vis (founder/genetic isolated) individuals

Chapter III

Study Statistics

Key metrics and study information

43217
Total Participants
GWAS
Study Type
Yes
Replicated
Up to 8,436 European ancestry individuals, up to 1,444 African American individuals
Replication Participants
African American or Afro-Caribbean, European
Ancestry
U.S., Iceland, Netherlands, U.K., Croatia, Austria, Republic of Ireland, Finland, Australia, Italy, Germany, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.